(2R)-2-(2,5-Difluorophenyl)pyrrolidine CAS:1218935-59-1: A Key Pharmaceutical Intermediate

(2R)-2-(2,5-Difluorophenyl)pyrrolidine is a critical pharmaceutical intermediate essential for the synthesis of advanced Trk kinase inhibitors. Explore its applications in developing targeted cancer therapies.

Get a Quote & Sample

Advantages Offered

High Purity Intermediate

Our (2R)-2-(2,5-difluorophenyl)pyrrolidine boasts a purity of 99.5%, ensuring reliable results in complex pharmaceutical synthesis, crucial for Trk kinase inhibitor development.

Critical for Trk Inhibitors

This compound is a key building block for imidazo[1,2-b]pyridazine derivatives, essential for creating potent inhibitors of Trk kinases used in targeted cancer therapies.

Reliable Supplier from China

Leveraging our manufacturing expertise in China, we offer a consistent and dependable supply of (2R)-2-(2,5-difluorophenyl)pyrrolidine for your research needs.

Key Applications

Trk Kinase Inhibitor Synthesis

Essential for the synthesis of Trk kinase inhibitors, which are vital in developing targeted cancer treatments. High purity ensures optimal reaction outcomes.

Pharmaceutical Research

Serves as a fundamental component in pharmaceutical research for novel drug discovery, particularly in oncology. Its specific chemical structure is key for building complex therapeutic molecules.

Organic Chemistry Building Blocks

As a versatile organic chemistry building block, it facilitates the creation of advanced molecular structures utilized in drug development and medicinal chemistry.

Targeted Cancer Therapies

Crucial for the development of targeted cancer therapies that rely on inhibiting specific kinases like TrkA, TrkB, and TrkC, offering new avenues for patient treatment.